SPY328.73+5.23 1.62%
DIA271.70+3.60 1.34%
IXIC10,913.56+241.30 2.26%

Sorrento Therapeutics shares are trading higher after the company announced on Thursday it has entered into a merger agreement to acquire SmartPharm and develop a pipeline of gene-encoded therapeutic antibodies, starting with neutralizing antibodies to treat Covid-19 and cancer therapeutics.

Benzinga · 08/21/2020 13:45